Nesyrgy (Amlodipine Besilate, Nebivolol Hydrochloride)

Amlodipine besilate and nebivolol hydrochloride, the active ingredients in Nesyrgy, are a calcium‑channel blocker and a β1‑selective beta‑blocker presented as an oral tablet for systemic use. They treat hypertension in adult patients by lowering blood pressure through vascular relaxation and reduced cardiac output.

GNH USA supplies Nesyrgy as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export to multiple regions, ensuring reliable supply chains and timely delivery.

Nesyrgy combines a calcium‑channel blocker and a β1‑selective beta‑blocker to manage hypertension and related blood‑pressure disorders.

Hypertension: reduces systolic and diastolic blood pressure, lowering cardiovascular risk. Isolated systolic hypertension: improves systolic pressure control in older adults. Diastolic hypertension: decreases diastolic pressure to target levels.

Adverse reactions reported with Nesyrgy are categorized as common and serious or rare.

Common Side Effects: - Headache - Peripheral edema - Flushing - Dizziness

Serious or Rare Side Effects: - Severe hypotension - Bradycardia - Angioedema

Before prescribing Nesyrgy, clinicians should consider several safety measures.

Monitor blood pressure regularly: adjust therapy as needed. Assess hepatic function before initiating therapy: consider dose adjustment in liver impairment. Evaluate for heart failure: use cautiously in decompensated patients. Use with caution in elderly: increased sensitivity to blood‑pressure lowering effects. Avoid abrupt discontinuation: may cause rebound hypertension. Store at room temperature: keep in original container, protect from moisture.

Nesyrgy may interact with other medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase amlodipine exposure. - Concomitant use with other antihypertensives (e.g., ACE inhibitors, diuretics): additive hypotensive effect. - Non‑dihydropyridine calcium‑channel blockers (e.g., verapamil): risk of excessive cardiac depression.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine): may raise nebivolol levels. - NSAIDs or alcohol: can attenuate blood‑pressure reduction or increase dizziness.